Days Sales in Receivables: The average number of days it takes to collect outstanding receivable amounts from customers. Calculated as: Number of Days in Period / Receivable Turnover
AnaptysBio, Inc. (ANAB) had Days Sales in Receivables of 28.14 for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$108.25M |
|
$49.61M |
|
-- |
|
$108.25M |
|
$41.35M |
|
$66.90M |
|
$-17.21M |
|
$49.70M |
|
$49.70M |
|
$49.61M |
|
$49.61M |
|
$49.61M |
|
$49.61M |
|
$66.90M |
|
$67.17M |
|
28.76M |
|
28.76M |
|
$1.62 |
|
$1.64 |
|
| Balance Sheet Financials | |
$350.25M |
|
$1.37M |
|
$14.14M |
|
$364.39M |
|
$38.62M |
|
-- |
|
$288.56M |
|
$327.19M |
|
$37.21M |
|
$37.21M |
|
$37.21M |
|
28.02M |
|
| Cash Flow Statement Financials | |
$19.70M |
|
$228.03M |
|
$-132.61M |
|
$123.08M |
|
$238.20M |
|
$115.12M |
|
$36.07M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
9.07 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
61.80% |
|
61.80% |
|
-- |
|
45.91% |
|
45.83% |
|
$19.61M |
|
-- |
|
-- |
|
-- |
|
0.30 |
|
-- |
|
3.20 |
|
|
Days Sales in Receivables |
28.14 |
133.34% |
|
133.34% |
|
13.62% |
|
133.34% |
|
$1.33 |
|
$0.68 |
|
$0.68 |
|